Herpes zoster and long-term risk of subjective cognitive decline.
APOE ε4
Herpes zoster
Immunocompromise
Prospective cohort study
Shingles
Subjective cognitive decline
Vaccination
Journal
Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643
Informations de publication
Date de publication:
14 Aug 2024
14 Aug 2024
Historique:
received:
22
01
2024
accepted:
20
06
2024
medline:
14
8
2024
pubmed:
14
8
2024
entrez:
13
8
2024
Statut:
epublish
Résumé
Herpes zoster (HZ), commonly known as "shingles," may contribute to cognitive decline through mechanisms such as neuroinflammation or direct neuronal injury. However, evidence on the longitudinal association between HZ and cognitive decline is conflicting and whether the risk differs by APOE ε4-carrier status has not been studied; prospective cohort studies on the association between HZ vaccination and cognitive decline are also lacking. We included 149,327 participants from three large cohorts-the Nurses' Health Study (NHS), NHSII, and Health Professionals Follow-Up Study (HPFS)-to prospectively examine the association between HZ and subsequent subjective cognitive decline (SCD). Poisson regression was used to estimate the multivariable-adjusted relative risk (MVRR) of a 3-unit increment in SCD score according to years since HZ compared with participants with no history of HZ. Compared with individuals with no history of HZ, the MVRR (95% CI) of a 3-unit increment in SCD score was significantly and independently higher among individuals with a history of HZ, but the duration of time since HZ when the elevated risk of SCD was statistically significant differed among the cohorts. In NHS, HZ was associated with higher long-term risk of SCD; compared with individuals with no history of HZ, the MVRR (95% CI) of a 3-unit increment in SCD score was 1.14 (1.01, 1.32) for ≥ 13 years since HZ. In NHS II, HZ was associated with higher risk of SCD in both the short-term [MVRR 1.34 (1.18, 1.53) for 1-4 years] and long-term [MVRR 1.20 (1.08, 1.34) for ≥ 13 years since HZ]. In HPFS, an elevated risk of SCD was suggested across all time points. Among the subset of participants with information on APOE ε4, there was a suggestion that the association differed by APOE ε4 carrier status, but the results were not consistent between women and men. Among the subset of women with information on HZ vaccination, there was a suggestion that the long-term risk of SCD may be greater among women who were not vaccinated against HZ. Data from three large independent cohorts of women and men showed that HZ was associated with higher long-term risk of SCD, and the risk may differ by APOE ε4-carrier status.
Sections du résumé
BACKGROUND
BACKGROUND
Herpes zoster (HZ), commonly known as "shingles," may contribute to cognitive decline through mechanisms such as neuroinflammation or direct neuronal injury. However, evidence on the longitudinal association between HZ and cognitive decline is conflicting and whether the risk differs by APOE ε4-carrier status has not been studied; prospective cohort studies on the association between HZ vaccination and cognitive decline are also lacking.
METHODS
METHODS
We included 149,327 participants from three large cohorts-the Nurses' Health Study (NHS), NHSII, and Health Professionals Follow-Up Study (HPFS)-to prospectively examine the association between HZ and subsequent subjective cognitive decline (SCD). Poisson regression was used to estimate the multivariable-adjusted relative risk (MVRR) of a 3-unit increment in SCD score according to years since HZ compared with participants with no history of HZ.
RESULTS
RESULTS
Compared with individuals with no history of HZ, the MVRR (95% CI) of a 3-unit increment in SCD score was significantly and independently higher among individuals with a history of HZ, but the duration of time since HZ when the elevated risk of SCD was statistically significant differed among the cohorts. In NHS, HZ was associated with higher long-term risk of SCD; compared with individuals with no history of HZ, the MVRR (95% CI) of a 3-unit increment in SCD score was 1.14 (1.01, 1.32) for ≥ 13 years since HZ. In NHS II, HZ was associated with higher risk of SCD in both the short-term [MVRR 1.34 (1.18, 1.53) for 1-4 years] and long-term [MVRR 1.20 (1.08, 1.34) for ≥ 13 years since HZ]. In HPFS, an elevated risk of SCD was suggested across all time points. Among the subset of participants with information on APOE ε4, there was a suggestion that the association differed by APOE ε4 carrier status, but the results were not consistent between women and men. Among the subset of women with information on HZ vaccination, there was a suggestion that the long-term risk of SCD may be greater among women who were not vaccinated against HZ.
CONCLUSIONS
CONCLUSIONS
Data from three large independent cohorts of women and men showed that HZ was associated with higher long-term risk of SCD, and the risk may differ by APOE ε4-carrier status.
Identifiants
pubmed: 39138535
doi: 10.1186/s13195-024-01511-x
pii: 10.1186/s13195-024-01511-x
doi:
Substances chimiques
Apolipoprotein E4
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
180Informations de copyright
© 2024. The Author(s).
Références
Wolters FJ, Ikram MA. Epidemiology of dementia: the Burden on Society, the Challenges for Research. Methods Mol Biol. 2018;1750:3–14.
pubmed: 29512062
doi: 10.1007/978-1-4939-7704-8_1
Yeh TS, Wang JD, Ku LE. Estimating Life Expectancy and Lifetime Healthcare costs for Alzheimer’s Disease in Taiwan: does the age of Disease Onset Matter? J Alzheimers Dis. 2020;73(1):307–15.
pubmed: 31771049
doi: 10.3233/JAD-181060
Warren-Gash C, Forbes HJ, Williamson E, Breuer J, Hayward AC, Mavrodaris A, et al. Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis. Sci Rep. 2019;9(1):4743.
pubmed: 30894595
pmcid: 6426940
doi: 10.1038/s41598-019-41218-w
Reynolds MA, Kruszon-Moran D, Jumaan A, Schmid DS, McQuillan GM. Varicella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999–2004. Public Health Rep. 2010;125(6):860–9.
pubmed: 21121231
pmcid: 2966667
doi: 10.1177/003335491012500613
Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices Centers for Disease C, Prevention. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR–5):1–30. quiz CE2-4.
pubmed: 18528318
Anwar MM. The emerging mechanism behind viral infections and extracellular vesicles hypotheses leading to neuroinflammation and Alzheimer’s disease pathology. Ibrain. 2023;9(1):63–71.
pubmed: 37786515
pmcid: 10529198
doi: 10.1002/ibra.12090
Chen VC, Wu SI, Huang KY, Yang YH, Kuo TY, Liang HY et al. Herpes zoster and dementia: a Nationwide Population-based Cohort Study. J Clin Psychiatry. 2018;79(1).
Tsai MC, Cheng WL, Sheu JJ, Huang CC, Shia BC, Kao LT, et al. Increased risk of dementia following herpes zoster ophthalmicus. PLoS ONE. 2017;12(11):e0188490.
pubmed: 29166672
pmcid: 5699837
doi: 10.1371/journal.pone.0188490
Shim Y, Park M, Kim J. Increased incidence of dementia following herpesvirus infection in the Korean population. Med (Baltim). 2022;101(41):e31116.
doi: 10.1097/MD.0000000000031116
Lophatananon A, Mekli K, Cant R, Burns A, Dobson C, Itzhaki R, et al. Shingles, Zostavax vaccination and risk of developing dementia: a nested case-control study-results from the UK Biobank cohort. BMJ Open. 2021;11(10):e045871.
pubmed: 34625411
pmcid: 8504358
doi: 10.1136/bmjopen-2020-045871
Warren-Gash C, Williamson E, Shiekh SI, Borjas-Howard J, Pearce N, Breuer JM, et al. No evidence that herpes zoster is associated with increased risk of dementia diagnosis. Ann Clin Transl Neurol. 2022;9(3):363–74.
pubmed: 35170873
pmcid: 8935278
doi: 10.1002/acn3.51525
Choi HG, Park BJ, Lim JS, Sim SY, Jung YJ, Lee SW. Herpes Zoster does not increase the risk of neurodegenerative dementia: a case-control study. Am J Alzheimers Dis Other Demen. 2021;36:15333175211006504.
pubmed: 33882722
pmcid: 11005322
doi: 10.1177/15333175211006504
Schmidt SAJ, Veres K, Sørensen HT, Obel N, Henderson VW. Incident herpes zoster and risk of dementia: a Population-based Danish cohort study. Neurology. 2022;99(7):e660–8.
pubmed: 35676090
pmcid: 9484607
doi: 10.1212/WNL.0000000000200709
Harris K, Ling Y, Bukhbinder AS, Chen L, Phelps KN, Cruz G, et al. The impact of routine vaccinations on Alzheimer’s disease risk in persons 65 years and older: a claims-based cohort study using propensity score matching. J Alzheimers Dis. 2023;95(2):703–18.
Scherrer JF, Salas J, Wiemken TL, Hoft DF, Jacobs C, Morley JE. Impact of herpes zoster vaccination on incident dementia: a retrospective study in two patient cohorts. PLoS ONE. 2021;16(11):e0257405.
pubmed: 34788293
pmcid: 8597989
doi: 10.1371/journal.pone.0257405
Lovheim H, Norman T, Weidung B, Olsson J, Josefsson M, Adolfsson R, et al. Herpes Simplex Virus, APOEvarepsilon4, and Cognitive decline in Old Age: results from the Betula Cohort Study. J Alzheimers Dis. 2019;67(1):211–20.
pubmed: 30636735
doi: 10.3233/JAD-171162
Linard M, Letenneur L, Garrigue I, Doize A, Dartigues JF, Helmer C. Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer’s disease. Alzheimers Dement. 2020;16(1):200–8.
pubmed: 31914220
doi: 10.1002/alz.12008
Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, et al. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry. 2014;22(12):1642–51.
pubmed: 24698445
pmcid: 4145054
doi: 10.1016/j.jagp.2014.02.007
Duara R, Loewenstein DA, Greig MT, Potter E, Barker W, Raj A, et al. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates. Am J Geriatr Psychiatry. 2011;19(11):951–60.
pubmed: 21422909
pmcid: 3175279
doi: 10.1097/JGP.0b013e3182107c69
Ulbl J, Rakusa M. The Importance of Subjective Cognitive Decline Recognition and the Potential of Molecular and Neurophysiological Biomarkers—A Systematic Review. International Journal of Molecular Sciences. 2023;24(12):10158.
Parfenov VA, Zakharov VV, Kabaeva AR, Vakhnina NV. Subjective cognitive decline as a predictor of future cognitive decline: a systematic review. Dement Neuropsychol. 2020;14(3):248–57.
pubmed: 32973979
pmcid: 7500809
doi: 10.1590/1980-57642020dn14-030007
Samieri C, Proust-Lima C, M MG, Okereke OI, Amariglio RE, Sperling RA, et al. Subjective cognitive concerns, episodic memory, and the APOE epsilon4 allele. Alzheimer’s Dement J Alzheimer’s Assoc. 2014;10(6):752–e91.
doi: 10.1016/j.jalz.2014.06.012
Yuan C, Fondell E, Bhushan A, Ascherio A, Okereke OI, Grodstein F, et al. Long-term intake of vegetables and fruits and subjective cognitive function in US men. Neurology. 2019;92(1):e63–75.
pubmed: 30464030
pmcid: 6336164
doi: 10.1212/WNL.0000000000006684
van Oijen M, de Jong FJ, Hofman A, Koudstaal PJ, Breteler MM. Subjective memory complaints, education, and risk of Alzheimer’s disease. Alzheimers Dement. 2007;3(2):92–7.
pubmed: 19595922
doi: 10.1016/j.jalz.2007.01.011
Yeh TS, Yuan C, Ascherio A, Rosner BA, Willett WC, Blacker D. Long-term Dietary Flavonoid Intake and Subjective Cognitive decline in US men and women. Neurology. 2021;97(10):e1041–56.
pubmed: 34321362
pmcid: 8448553
doi: 10.1212/WNL.0000000000012454
Amariglio RE, Townsend MK, Grodstein F, Sperling RA, Rentz DM. Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc. 2011;59(9):1612–7.
pubmed: 21919893
pmcid: 3315361
doi: 10.1111/j.1532-5415.2011.03543.x
Yeh TS, Yuan C, Ascherio A, Rosner BA, Blacker D, Willett WC. Long-term dietary protein intake and subjective cognitive decline in US men and women. Am J Clin Nutr. 2022;115(1):199–210.
pubmed: 34293099
doi: 10.1093/ajcn/nqab236
Yeh TS, Yuan C, Ascherio A, Rosner BA, Blacker D, Willett WC. Long-term intake of total energy and fat in relation to subjective cognitive decline. Eur J Epidemiol. 2022;37(2):133–46.
pubmed: 34748116
doi: 10.1007/s10654-021-00814-9
Kang JH, Logroscino G, De Vivo I, Hunter D, Grodstein F. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging. 2005;26(4):475–84.
pubmed: 15653176
doi: 10.1016/j.neurobiolaging.2004.05.003
Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, et al. Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292–323.
pubmed: 27012484
doi: 10.1016/j.jalz.2016.02.002
Levine KS, Leonard HL, Blauwendraat C, Iwaki H, Johnson N, Bandres-Ciga S et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron. 2023.
Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004;148(1):99–104.
pubmed: 15215798
doi: 10.1016/j.ahj.2004.02.013
Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236–42.
pubmed: 21351304
doi: 10.1002/pds.2087
Yawn BP, Wollan P, St Sauver J. Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol. 2011;174(9):1054–61.
pubmed: 21920944
pmcid: 3243933
doi: 10.1093/aje/kwr206
Erskine N, Tran H, Levin L, Ulbricht C, Fingeroth J, Kiefe C, et al. A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS ONE. 2017;12(7):e0181565.
pubmed: 28749981
pmcid: 5531458
doi: 10.1371/journal.pone.0181565
Schnier C, Janbek J, Lathe R, Haas J. Reduced dementia incidence after varicella zoster vaccination in Wales 2013–2020. Alzheimers Dement (N Y). 2022;8(1):e12293.
pubmed: 35434253
doi: 10.1002/trc2.12293
Bae S, Yun SC, Kim MC, Yoon W, Lim JS, Lee SO, et al. Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur Arch Psychiatry Clin Neurosci. 2021;271(5):987–97.
pubmed: 32613564
doi: 10.1007/s00406-020-01157-4
Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW. Varicella-Zoster virus activates inflammatory cytokines in human monocytes and macrophages via toll-like receptor 2. J Virol. 2005;79(20):12658–66.
pubmed: 16188968
pmcid: 1235827
doi: 10.1128/JVI.79.20.12658-12666.2005
Bubak AN, Coughlan C, Posey J, Saviola AJ, Niemeyer CS, Lewis SWR et al. Zoster-associated prothrombotic plasma exosomes and increased stroke risk. J Infect Dis. 2022.
O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2(2):89–98.
pubmed: 12849265
doi: 10.1016/S1474-4422(03)00305-3
Pendlebury ST, Rothwell PM, Oxford Vascular S. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019;18(3):248–58.
pubmed: 30784556
pmcid: 6390174
doi: 10.1016/S1474-4422(18)30442-3
Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 1992;42(6):1185–93.
pubmed: 1603346
doi: 10.1212/WNL.42.6.1185
Curhan SG, Kawai K, Yawn B, Rexrode KM, Rimm EB, Curhan GC. Herpes zoster and long-term risk of Cardiovascular Disease. J Am Heart Assoc. 2022;11(23):e027451.
pubmed: 36382961
pmcid: 9851464
doi: 10.1161/JAHA.122.027451
Mescher T, Boyer PJ, Bubak AN, Hassell JE Jr., Nagel MA. Detection of varicella zoster virus antigen and DNA in two cases of cerebral amyloid angiopathy. J Neurol Sci. 2021;422:117315.
pubmed: 33503519
pmcid: 7935758
doi: 10.1016/j.jns.2021.117315
Cairns DM, Itzhaki RF, Kaplan DL. Potential involvement of Varicella Zoster Virus in Alzheimer’s Disease via Reactivation of quiescent herpes simplex virus type 1. J Alzheimers Dis. 2022;88(3):1189–200.
pubmed: 35754275
doi: 10.3233/JAD-220287
Ou YN, Zhu JX, Hou XH, Shen XN, Xu W, Dong Q, et al. Associations of Infectious agents with Alzheimer’s Disease: a systematic review and Meta-analysis. J Alzheimers Dis. 2020;75(1):299–309.
pubmed: 32280095
doi: 10.3233/JAD-191337
Sochocka M, Zwolinska K, Leszek J. The infectious etiology of Alzheimer’s Disease. Curr Neuropharmacol. 2017;15(7):996–1009.
pubmed: 28294067
pmcid: 5652018
doi: 10.2174/1570159X15666170313122937
Damiano RF, Guedes BF, de Rocca CC, de Padua Serafim A, Castro LHM, Munhoz CD, et al. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci. 2022;272(1):139–54.
pubmed: 34173049
doi: 10.1007/s00406-021-01286-4
Kim MY, Kim K, Hong CH, Lee SY, Jung YS. Sex differences in Cardiovascular Risk factors for Dementia. Biomol Ther (Seoul). 2018;26(6):521–32.
pubmed: 30464071
doi: 10.4062/biomolther.2018.159
Lahoz C, Schaefer EJ, Cupples LA, Wilson PW, Levy D, Osgood D, et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis. 2001;154(3):529–37.
pubmed: 11257253
doi: 10.1016/S0021-9150(00)00570-0
Altmann A, Tian L, Henderson VW, Greicius MD. Alzheimer’s Disease Neuroimaging Initiative I. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014;75(4):563–73.
pubmed: 24623176
pmcid: 4117990
doi: 10.1002/ana.24135
Ungar L, Altmann A, Greicius MD. Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction. Brain Imaging Behav. 2014;8(2):262–73.
pubmed: 24293121
pmcid: 4282773
doi: 10.1007/s11682-013-9272-x
Hohman TJ, Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, et al. Sex-Specific Association of Apolipoprotein E with cerebrospinal fluid levels of tau. JAMA Neurol. 2018;75(8):989–98.
pubmed: 29801024
pmcid: 6142927
doi: 10.1001/jamaneurol.2018.0821
Yaffe K, Haan M, Byers A, Tangen C, Kuller L. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology. 2000;54(10):1949–54.
pubmed: 10822435
doi: 10.1212/WNL.54.10.1949
Kang JH, Grodstein F. Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline. Neurobiol Aging. 2012;33(7):1129–37.
pubmed: 21122949
doi: 10.1016/j.neurobiolaging.2010.10.007
Hogervorst E, Lehmann DJ, Warden DR, McBroom J, Smith AD. Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer’s disease in men. Int J Geriatr Psychiatry. 2002;17(10):938–40.
pubmed: 12325053
doi: 10.1002/gps.714
Pfankuch T, Rizk A, Olsen R, Poage C, Raber J. Role of circulating androgen levels in effects of apoE4 on cognitive function. Brain Res. 2005;1053(1–2):88–96.
pubmed: 16054121
doi: 10.1016/j.brainres.2005.06.028
Carter CL, Resnick EM, Mallampalli M, Kalbarczyk A. Sex and gender differences in Alzheimer’s disease: recommendations for future research. J Womens Health (Larchmt). 2012;21(10):1018–23.
pubmed: 22917473
doi: 10.1089/jwh.2012.3789
Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology. 2013;80(19):1778–83.
pubmed: 23390181
pmcid: 3719424
doi: 10.1212/WNL.0b013e31828726f5
Brown MJ, Patterson R. Subjective cognitive decline among sexual and gender minorities: results from a U.S. Population-based sample. J Alzheimers Dis. 2020;73(2):477–87.
pubmed: 31796675
pmcid: 7299090
doi: 10.3233/JAD-190869
Lee SH, Kang Y, Cho SJ. Subjective cognitive decline in patients with migraine and its relationship with depression, anxiety, and sleep quality. J Headache Pain. 2017;18(1):77.
pubmed: 28744704
pmcid: 5526827
doi: 10.1186/s10194-017-0779-1
Schliep KC, Barbeau WA, Lynch KE, Sorweid MK, Varner MW, Foster NL, et al. Overall and sex-specific risk factors for subjective cognitive decline: findings from the 2015–2018 behavioral risk factor Surveillance System Survey. Biology Sex Differences. 2022;13(1):16.
doi: 10.1186/s13293-022-00425-3
Akhter F, Persaud A, Zaokari Y, Zhao Z, Zhu D. Vascular dementia and underlying sex differences. Front Aging Neurosci. 2021;13:720715.
pubmed: 34566624
pmcid: 8457333
doi: 10.3389/fnagi.2021.720715
Samieri C, Proust-Lima C, M MG, Okereke OI, Amariglio RE, Sperling RA, et al. Subjective cognitive concerns, episodic memory, and the APOE epsilon4 allele. Alzheimers Dement. 2014;10(6):752–e91.
pubmed: 25256133
doi: 10.1016/j.jalz.2014.06.012
Amariglio RE, Becker JA, Carmasin J, Wadsworth LP, Lorius N, Sullivan C, et al. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia. 2012;50(12):2880–6.
pubmed: 22940426
pmcid: 3473106
doi: 10.1016/j.neuropsychologia.2012.08.011
Amariglio RE, Mormino EC, Pietras AC, Marshall GA, Vannini P, Johnson KA, et al. Subjective cognitive concerns, amyloid-beta, and neurodegeneration in clinically normal elderly. Neurology. 2015;85(1):56–62.
pubmed: 26048028
pmcid: 4501939
doi: 10.1212/WNL.0000000000001712